BRCA2 loss in Fanconi Anemia

被引：0
|
作者：
Weitzman J.B.
机构：
来源：
Genome Biology | / 3卷 / 1期
关键词：
Breast Cancer; Anemia; Cancer Susceptibility; Fanconi Anemia; Breast Cancer Susceptibility;
D O I：
10.1186/gb-spotlight-20020614-01
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [21] The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
    Myers, Kasiani
    Davies, Stella M.
    Harris, Richard E.
    Spunt, Sheri L.
    Smolarek, Teresa
    Zimmerman, Sarah
    McMasters, Richard
    Wagner, Lars
    Mueller, Robin
    Auerbach, Arleen D.
    Mehta, Parinda A.
    PEDIATRIC BLOOD & CANCER, 2012, 58 (03) : 462 - 465
  • [22] Interleukin-2-induced Graft-Versus-Leukemia for the Treatment of AML in a BRCA2 Fanconi Anemia Patient
    Yeo, Crystal J. J.
    Gilman, Andrew L.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (02) : E78 - E80
  • [23] Multiple synchronous malignancies in an infant with concomitant homozygous BRCA2 and PMS2 mutations with Fanconi anemia phenotype
    Alghanim, Hamad Mohammed
    Eltawel, Mohamed
    Alhaidari, Abdulmajeed Ibrahim
    Alobaid, Muhannad Mohammed
    Moghairi, Areej Mofareh
    Sufiani, Fahad
    Ahmad, Naveed
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2023, 40 (06) : 587 - 594
  • [24] Cross-links between Fanconi anaemia and BRCA2
    West, SC
    DNA REPAIR, 2003, 2 (02) : 231 - 234
  • [25] Generation of Disease-free iPS Cells from Fanconi Anemia Mice with a Hypomorphic Mutation in Brca2
    Moleiro, V.
    Navarro, S.
    Lozano, M. L.
    Chinchon, R.
    Almarza, E.
    Quintana-Bustamante, O.
    Rio, P.
    Mostoslavsky, G.
    Maetzig, T.
    Schiedlmeier, B.
    Modlich, U.
    Galla, M.
    Samper, E.
    Segovia, J. C.
    Raya, A.
    Gueenechea, G.
    Baum, C.
    Izpisua-Belmonte, J. C.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2012, 23 (10) : A41 - A41
  • [26] Homozygosity mapping and mutation screening in a family with unclassified Fanconi anemia identifies an unusual BRCA2 mutation.
    Rischewski, JR
    Hoffmann, K
    Lindner, TH
    Hanenberg, H
    Michael, K
    Obser, T
    Schindler, D
    Nuernberg, P
    Schneppenheim, R
    BLOOD, 2002, 100 (11) : 741A - 742A
  • [27] Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2
    Godthelp, Barbara C.
    van Buul, Paul P. W.
    Jaspers, Nicolaas G. J.
    Elghalbzouri-Maghrani, Elhaam
    van Duijn-Goedhart, Annemarie
    Arwert, Fre
    Joenje, Hans
    Zdzienicka, Malgorzata Z.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 601 (1-2) : 191 - 201
  • [28] Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia
    Wagner, JE
    Tolar, J
    Levran, O
    Scholl, T
    Deffenbaugh, A
    Satagopan, J
    Ben-Porat, L
    Mah, K
    Batish, SD
    Kutler, DI
    MacMillan, ML
    Hanenberg, H
    Auerbach, AD
    BLOOD, 2004, 103 (08) : 3226 - 3229
  • [29] Targeting the Fanconi anemia/BRCA pathway
    D'Andrea, Alan D.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [30] FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex
    Raghunandan, Maya
    Chaudhury, Indrajit
    Kelich, Stephanie L.
    Hanenberg, Helmut
    Sobeck, Alexandra
    CELL CYCLE, 2015, 14 (03) : 342 - 353
12345